Oncohema Key

INTRODUCTION Print Section Listen “Nature often gives us hints to her profoundest secrets, and it is possible that she has given us a hint which, if we will but follow,…

INTRODUCTION Print Section Listen The management of uncommon and rare cutaneous malignancies can be challenging due the lack of high-quality evidence for guidance. They include a varied group of skin…

INTRODUCTION Print Section Listen Among individuals diagnosed with bone or soft tissue sarcoma, approximately 10% will have metastatic disease at the time of presentation,1–6 and an estimated 40% will develop…

INTRODUCTION Print Section Listen Approximately 15% of soft tissue sarcomas (STS) occur in the retroperitoneum, and thus, there are only approximately 1600 new retroperitoneal sarcomas (RPS) in the United States…

INTRODUCTION Print Section Listen Benign soft tissue tumors and reactive lesions are encountered frequently in Surgical Oncology practice. While benign, these lesions often cause local symptoms, and they may mimic…

INTRODUCTION Print Section Listen Revisions to the melanoma staging system were published in the seventh edition of the American Joint Committee on Cancer manual (AJCC Cancer Staging Manual) in 2009…

BACKGROUND Print Section Listen Squamous cell carcinoma (SCC) is the second most common form of skin cancer after basal cell carcinoma (BCC). In 1775, Percival Pott published “Chirurgical Observations Relative…

INTRODUCTION Print Section Listen Metastatic melanoma continues to place a substantial economic burden on western caucasian populations because of the disproportionately high incidence in young patients.1 Historically, the prognosis for…

MANAGEMENT OF PRIMARY MELANOMA Print Section Listen The incidence of melanoma is increasing worldwide. In the United States, it is estimated that there will be 76,380 new cases of invasive…